Expression of HER2 and MUC1 in Advanced Colorectal Cancer: Frequency and Clinicopathological Characteristics
作者： Kunio ASONUMA , Yuko DATE , Genki TSUKUDA , Kodai HIRABAYASHI , Yuusuke WADA
DOI: 10.15369/SUJMS.25.93
关键词: Expression (architecture) 、 Medicine 、 Advanced colorectal cancer 、 Internal medicine 、 Oncology 、 MUC1
摘要:
sci-hub.st 参考文章(21)
M.H. Kraus, N.C. Popescu, S.C. Amsbaugh, C.R. King, Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms The EMBO Journal. ,vol. 6, pp. 605- 610 ,(1987) , 10.1002/J.1460-2075.1987.TB04797.X
Shoji Nakamori, David M. Ota, Karen R. Cleary, Keiro Shirotani, Tatsuro Irimura, MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma Gastroenterology. ,vol. 106, pp. 353- 361 ,(1994) , 10.1016/0016-5085(94)90592-4
Maria Teresa Ramieri, Piero Luigi Alo, Claudio Botti, Riccardo Murari, Emanuela Pica, Giancarlo Zotti, Detection of HER2 Amplification Using the SISH Technique in Breast, Colon, Prostate, Lung and Ovarian Carcinoma Anticancer Research. ,vol. 30, pp. 1287- 1292 ,(2010)
Amanda McCann, Peter A. Dervan, P. A. Johnston, Desmond N. Carney, William J. Gullick, c-erbB-2 oncoprotein expression in primary human tumors Cancer. ,vol. 65, pp. 88- 92 ,(1990) , 10.1002/1097-0142(19900101)65:1<88::AID-CNCR2820650119>3.0.CO;2-Z
Masakazu Nakajima, Hidetomo Sawada, Yukishige Yamada, Akihiko Watanabe, Mitsutoshi Tatsumi, Jun Yamashita, Masahiko Matsuda, Teruyuki Sakaguchi, Tomoko Hirao, Hiroshige Nakano, The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer. ,vol. 85, pp. 1894- 1902 ,(1999) , 10.1002/(SICI)1097-0142(19990501)85:9<1894::AID-CNCR3>3.0.CO;2-J
Aihua Li, Masamichi Goto, Michiko Horinouchi, Sadao Tanaka, Kohzoh Imai, Young S. Kim, Eiichi Sato, Suguru Yonezawa, Expression of MUC1 and MUC2 mucins and relationship with cell proliferative activity in human colorectal neoplasia Pathology International. ,vol. 51, pp. 853- 860 ,(2001) , 10.1046/J.1440-1827.2001.01291.X
Y Ajioka, H Watanabe, J R Jass, MUC1 and MUC2 mucins in flat and polypoid colorectal adenomas. Journal of Clinical Pathology. ,vol. 50, pp. 417- 421 ,(1997) , 10.1136/JCP.50.5.417
Jun Yokota, Kumao Toyoshima, Takashi Sugimura, Tadashi Yamamoto, Masaaki Terada, Hector Battifora, MartinJ Cline, Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. The Lancet. ,vol. 327, pp. 765- 767 ,(1986) , 10.1016/S0140-6736(86)91782-4
Dara O Kavanagh, Gillian Chambers, Liam O' Grady, Kevin M Barry, Ronan P Waldron, Fadel Bennani, Paul W Eustace, Iqdam Tobbia, Is overexpression of HER-2 a predictor of prognosis in colorectal cancer? BMC Cancer. ,vol. 9, pp. 1- 6 ,(2009) , 10.1186/1471-2407-9-1
Shawn P. Fessler, Mark T. Wotkowicz, Sanjeev K. Mahanta, Cynthia Bamdad, MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells. Breast Cancer Research and Treatment. ,vol. 118, pp. 113- 124 ,(2009) , 10.1007/S10549-009-0412-3